Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell Labeling

Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell Labeling

Saved in:

Bibliographic Details
Main Authors:	Guoyun Kao, Xiao-Nan Zhang, Fariborz Nasertorabi, Benjamin B. Katz, Zeyang Li, Zhefu Dai, Zeyu Zhang, Lei Zhang, Stan G. Louie, Vadim Cherezov, Yong Zhang
Format:	Article
Language:	English
Published:	American Chemical Society 2024-10-01
Series:	JACS Au
Online Access:	https://doi.org/10.1021/jacsau.4c00695
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effects of Nicotinamide Riboside Supplementation on Postmortem Mitochondrial Functionality and Apoptotic Activation
by: Chen Zhu, et al.
Published: (2025-01-01)

Determination of NAD+ precursors nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) in plant foods: exploring dietary sources
by: Gabriela Fabiana Soares Alegre, et al.
Published: (2025-12-01)

Rational Design for Improving the Thermostability of Saccharomyces cerevisiae Nicotinamide Riboside Kinase 1
by: WANG Yao, SHEN Taisong, LI Sichen, SHI Hongling, YAO Lunguang, TANG Cunduo
Published: (2024-12-01)

Nicotinamide riboside supplementation ameliorates ovarian dysfunction in a PCOS mouse model
by: Zhenye Zhu, et al.
Published: (2025-01-01)

Urolithin A and nicotinamide riboside differentially regulate innate immune defenses and metabolism in human microglial cells
by: Helena Borland Madsen, et al.
Published: (2024-11-01)

Effects of meta-topolin riboside and meta-methoxy topolin riboside on the in vitro micropropagation of Pyrus communis L.
by: Natalia G. Dimitrova, et al.
Published: (2024-11-01)

Novel Approach to Skin Anti-Aging: Boosting Pharmacological Effects of Exogenous Nicotinamide Adenine Dinucleotide (NAD<sup>+</sup>) by Synergistic Inhibition of CD38 Expression
by: Seongsu Kang, et al.
Published: (2024-10-01)

CD56briCD38+ as a novel neutrophil-specific marker in chronic myeloid leukemia
by: Panpan Huang, et al.
Published: (2024-11-01)

CD38 as theranostic target in oncology
by: Valentina Bocuzzi, et al.
Published: (2024-11-01)

Research progress in dynamic covalent thermosets and their composites based on dynamic covalent bonds
by: WU Jianqiao, et al.
Published: (2024-11-01)

De novo biosynthesis and nicotinamide biotransformation of nicotinamide mononucleotide by engineered yeast cells
by: Yanna Ren, et al.
Published: (2024-11-01)

Correction to: CD38 as theranostic target in oncology
by: Valentina Bocuzzi, et al.
Published: (2024-12-01)

The Regulation between CD4+CXCR5+ Follicular Helper T (Tfh) Cells and CD19+CD24hiCD38hi Regulatory B (Breg) Cells in Gastric Cancer
by: Ying Zhang, et al.
Published: (2022-01-01)

Deletion of CD38 enhances CD19 chimeric antigen receptor T cell function
by: Kimberly Veliz, et al.
Published: (2024-06-01)

High-affinity CD16 integration into a CRISPR/Cas9-edited CD38 locus augments CD38-directed antitumor activity of primary human natural killer cells
by: Long Chen, et al.
Published: (2022-02-01)

CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity
by: John F. Imbery, et al.
Published: (2024-09-01)

PD-1 suppresses human CD38+ circulating Tfr cells and regulates humoral immunity
by: Heng Zhang, et al.
Published: (2025-01-01)

The involvement of nicotinate and nicotinamide metabolism pathway in attenuating benzene-induced mouse hematotoxicity
by: Rongfang Yang, et al.
Published: (2024-12-01)

Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects
by: Alberto L. Horenstein, et al.
Published: (2025-02-01)

ANTI-CD38 MONOCLONAL ANTIBODIES: TRANSFORMING MULTIPLE MYELOMA TREATMENT
by: Cem Selim
Published: (2024-12-01)

Functional identification of soluble uric acid as an endogenous inhibitor of CD38
by: Shijie Wen, et al.
Published: (2024-11-01)

Increased TLR4 Expression Aggravates Sepsis by Promoting IFN-γ Expression in CD38−/− Mice
by: Qi Li, et al.
Published: (2019-01-01)

The role of the gut microbiota and the nicotinate/nicotinamide pathway in rotenone-induced neurotoxicity
by: Yan Sai, et al.
Published: (2025-01-01)

Wnt1 Accelerates an Ex Vivo Expansion of Human Cord Blood CD34+CD38− Cells
by: Kamonnaree Chotinantakul, et al.
Published: (2013-01-01)

Truncating the C terminus of formate dehydrogenase leads to improved preference to nicotinamide cytosine dinucleotide
by: Xiaojia Guo, et al.
Published: (2024-11-01)

Illuminating the impact of CD38-induced adenosine formation in B-cell lymphoma
by: Shams ElDoha Galal ElDin Zaiema, et al.
Published: (2025-01-01)

CD38 deletion to preserve CAR T cell metabolism and promote functional persistence
by: Viviana Rubino, et al.
Published: (2024-09-01)

Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men
by: Shintaro Yamaguchi, et al.
Published: (2024-02-01)

Advancements, challenges, and future frontiers in covalent inhibitors and covalent drugs: A review
by: Muhammad Salman Hameed, et al.
Published: (2024-12-01)

INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
by: Duni Sawadogo, et al.
Published: (2013-04-01)

Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells
by: Luciana Melo Garcia, et al.
Published: (2025-01-01)

CD2AP deficiency aggravates Alzheimer’s disease phenotypes and pathology through p38 MAPK activation
by: Yan-Yan Xue, et al.
Published: (2024-12-01)

Apigenin inhibits NLRP3 inflammasome activation in monocytes and macrophages independently of CD38
by: Knut Husø Lauritzen, et al.
Published: (2025-01-01)

Preclinical evaluation of the CD38‐targeting engineered toxin body MT‐0169 against multiple myeloma
by: Wassilis S. C. Bruins, et al.
Published: (2024-11-01)

Nicotinamide Increases the Physiological Performance and Initial Growth of Maize Plant
by: Tassila Aparecida do Nascimento de Araújo, et al.
Published: (2024-01-01)

Level of CD8 T Lymphocytes Activation in HIV-Infected Pregnant Women: In the Context of CD38 and HLA-DR Activation Markers
by: Stanslaus Musyoki, et al.
Published: (2014-01-01)

The study of halogen effect on the reactivity of the serine-targeting covalent warheads
by: Conghao Gai, et al.
Published: (2024-12-01)

Construction of functional covalent organic framework films by modulator and solvent induced polymerization
by: Xuerong Li, et al.
Published: (2025-01-01)

Dysregulated CD38 expression on T cells was associated with rapidly progressive interstitial lung disease in anti-melanoma differentiation-associated gene 5 positive dermatomyositis
by: Yixue Guo, et al.
Published: (2024-11-01)

Nicotinamide Mononucleotide Alleviates Bile Acid Metabolism and Hormonal Dysregulation in Letrozole-Induced PCOS Mice
by: Caifang Ren, et al.
Published: (2024-12-01)